ECG
A newly published notice from the FDA suggests a new capability for the Alphabet subsidiary's clinical research wearable.
The new features are designed to help wearers detect the risk of atrial fibrillation and sleep apnea.
From mobile ECGs to tele-rehabilitation to defibrillator delivery drones, a range of new data was on display at the American Heart Association Scientific Sessions 2019.
The news comes just a few months after AliveCor ended the sales of its FDA-cleared ECG wearable KardiaBand.
Once Fitbit has cleared its own atrial fibrillation detection feature, it will be working with the pharmas to develop content that will help at-risk users discuss their heart health with a provider.
The item could measure blood pressure, respiration rate and ECG signals.
The software combines ECG readings with artificial intelligence to deliver personalized workout guidance.
Also: Women's health apps launch PCOS screening tools; uBiome files for bankruptcy.
The news comes roughly eight months after Apple launched its own hardware and software ECG feature for the Apple Watch Series 4.
Priya Abani will take up the digital health company's top role on Monday, while interim CEO Ira Bahr will shift to the COO position.